A RETROSPECTIVE STUDY ON EVALUATION OF ANTIBIOTIC UTILIZATION IN RENAL IMPAIRMENT IN A TERTIARY CARE HOSPITAL IN DAKSHINA KANNADA DISTRICT

Reference

1. Luo X, Jiang L, Du B, Wen Y, Wang M, Xi X, et al. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Critical Care. 2014; 18(4): 1-8.
2. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International. 2011; 80(1): 17–28.
3. Shrestha N, Gautam S, Mishra SR, Virani SS, Dhungana RR. Burden of chronic kidney disease in the general population and high-risk groups in South Asia. PLoS One. 2021; 16(10): 1-19.
4. Griffin BR, You Z, Holmen J, SooHoo M, Gist KM, Colbert JF, Chonchol M, Faubel S, Jovanovich A. Incident infection following acute kidney injury with recovery to baseline creatinine: A propensity score matched analysis. PLoS One. 2019; 14(6): 1-13.

5. MacRae C, Mercer SW, Guthrie B, Henderson D. Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care. British Journal of General Practice. 2021; 71(704): 243–9.
6. Shankar M, Narasimhappa S, Madhura. Urinary tract infection in chronic kidney disease population: A clinical observational study. Cureus. 2021; 13(1): 1-9.
7. Chou CY, Wang SM, Liang CC, Chang CT, Liu JH, Wang I-Kuan, et al. Risk of Pneumonia Among Patients With Chronic Kidney Disease in Outpatient and Inpatient Settings: a nationwide population-based study. Medicine. 2014; 93(27): 1-4.
8. Bou Chebl R, Tamim H, Abou Dagher G, Sadat M, Ghamdi G, Itani A, et al. Sepsis in end-stage renal disease patients: are they at an increased risk of mortality? Annals of Medicine. 2021; 53(1): 1737–43.
9. Hui K, Nalder M, Buising K, Pefanis A, Ooi KY, Pedagogos E, et al. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study. BMC Nephrology. 2017; 18(1): 1-9.
10. Kourkouta L, Tsaloglidou A, Koukourikos K, Iliadis C, Plati P., Dimitriadou A., History of Antibiotics. Sumerianz Journal of Medical and Healthcare. 2018; 1(2): 51-54.
11. Fraser SD, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrology. 2015; 16(1): 1-11.
12. Bábí?ková J, Klinkhammer BM, Buhl EM, Djudjaj S, Hoss M, Heymann F, et al. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney International. 2017; 91(1):70–85.
13. Hsu CY, Fang H, Kang Wei Chou, Chen CL, Lee PT, Chung HM. The Clinical Impact of Bacteremia in Complicated Acute Pyelonephritis. The American Journal of the Medical Sciences. 2006; 332(4):175–80.
14. Dalrymple LS, Mu Y, Nguyen DV, Romano PS, Chertow GM, Grimes B, et al. Risk factors for infection-related hospitalization in in-center hemodialysis. Clinical Journal of  American Society of  Nephrology. 2015; 10(12): 2170–80.
15. Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, Ladipo GOA, Al-Rubaish A. A prospective study of hemodialysis access-related bacterial infections. Journal of Infection and Chemotherapy. 2002; 8(3): 242–6.
16. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009; 136(5): 1237–48.
17. Al Himali N, Al Suleimani YM, Al-Zakwani I, Abdelrahman AM. Antibiotics utilization patterns and dosage appropriateness among patients receiving hemodialysis. Saudi Pharmaceutical Journal. 2022; 30(7): 971–8